These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 34245591)

  • 1. A bird's eye view on the role of dendritic cells in SARS-CoV-2 infection: Perspectives for immune-based vaccines.
    Galati D; Zanotta S; Capitelli L; Bocchino M
    Allergy; 2022 Jan; 77(1):100-110. PubMed ID: 34245591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dendritic cells in COVID-19 immunopathogenesis: insights for a possible role in determining disease outcome.
    Borges RC; Hohmann MS; Borghi SM
    Int Rev Immunol; 2021; 40(1-2):108-125. PubMed ID: 33191813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dendritic Cells and SARS-CoV-2 Infection: Still an Unclarified Connection.
    Campana P; Parisi V; Leosco D; Bencivenga D; Della Ragione F; Borriello A
    Cells; 2020 Sep; 9(9):. PubMed ID: 32911691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Severe acute respiratory syndrome coronavirus 2 virus-like particles induce dendritic cell maturation and modulate T cell immunity.
    Mi Y; Liang L; Xu K; Li Q; Wang W; Dang W; Deng J; Zhi Y; Li X; Tan J
    Front Cell Infect Microbiol; 2022; 12():986350. PubMed ID: 36439228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Attenuated Interferon and Proinflammatory Response in SARS-CoV-2-Infected Human Dendritic Cells Is Associated With Viral Antagonism of STAT1 Phosphorylation.
    Yang D; Chu H; Hou Y; Chai Y; Shuai H; Lee AC; Zhang X; Wang Y; Hu B; Huang X; Yuen TT; Cai JP; Zhou J; Yuan S; Zhang AJ; Chan JF; Yuen KY
    J Infect Dis; 2020 Aug; 222(5):734-745. PubMed ID: 32563187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Depletion and Dysfunction of Dendritic Cells: Understanding SARS-CoV-2 Infection.
    Chang T; Yang J; Deng H; Chen D; Yang X; Tang ZH
    Front Immunol; 2022; 13():843342. PubMed ID: 35265087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contribution of monocytes and macrophages to the local tissue inflammation and cytokine storm in COVID-19: Lessons from SARS and MERS, and potential therapeutic interventions.
    Jafarzadeh A; Chauhan P; Saha B; Jafarzadeh S; Nemati M
    Life Sci; 2020 Sep; 257():118102. PubMed ID: 32687918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of dendritic cells in COVID-19 infection.
    Wang X; Guan F; Miller H; Byazrova MG; Cndotti F; Benlagha K; Camara NOS; Lei J; Filatov A; Liu C
    Emerg Microbes Infect; 2023 Dec; 12(1):2195019. PubMed ID: 36946172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune response in COVID-19: addressing a pharmacological challenge by targeting pathways triggered by SARS-CoV-2.
    Catanzaro M; Fagiani F; Racchi M; Corsini E; Govoni S; Lanni C
    Signal Transduct Target Ther; 2020 May; 5(1):84. PubMed ID: 32467561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SARS-CoV-2 will constantly sweep its tracks: a vaccine containing CpG motifs in 'lasso' for the multi-faced virus.
    Oberemok VV; Laikova KV; Yurchenko KA; Marochkin NA; Fomochkina II; Kubyshkin AV
    Inflamm Res; 2020 Sep; 69(9):801-812. PubMed ID: 32656668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DCs-based therapies: potential strategies in severe SARS-CoV-2 infection.
    Han J; Sun J; Zhang G; Chen H
    Int J Med Sci; 2021; 18(2):406-418. PubMed ID: 33390810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Innate Immune Signaling and Proteolytic Pathways in the Resolution or Exacerbation of SARS-CoV-2 in Covid-19: Key Therapeutic Targets?
    Sallenave JM; Guillot L
    Front Immunol; 2020; 11():1229. PubMed ID: 32574272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Harnessing the immune system to overcome cytokine storm and reduce viral load in COVID-19: a review of the phases of illness and therapeutic agents.
    Khadke S; Ahmed N; Ahmed N; Ratts R; Raju S; Gallogly M; de Lima M; Sohail MR
    Virol J; 2020 Oct; 17(1):154. PubMed ID: 33059711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Developing dendritic cell for SARS-CoV-2 vaccine: Breakthrough in the pandemic.
    Jonny J; Putranto TA; Irfon R; Sitepu EC
    Front Immunol; 2022; 13():989685. PubMed ID: 36148241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Innate and adaptive immune response in SARS-CoV-2 infection-Current perspectives.
    Zhu Q; Xu Y; Wang T; Xie F
    Front Immunol; 2022; 13():1053437. PubMed ID: 36505489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dysregulated Interferon Response and Immune Hyperactivation in Severe COVID-19: Targeting STATs as a Novel Therapeutic Strategy.
    Eskandarian Boroujeni M; Sekrecka A; Antonczyk A; Hassani S; Sekrecki M; Nowicka H; Lopacinska N; Olya A; Kluzek K; Wesoly J; Bluyssen HAR
    Front Immunol; 2022; 13():888897. PubMed ID: 35663932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SARS-CoV-2 Detection and COVID-19 Diagnosis: A Bird's Eye View.
    Alzahrani AR; Jabeen Q; Shahid I; Al-Ghamdi SS; Shahzad N; Rehman S; Algarni AS; Bamagous GA; AlanazI IMM; Ibrahim IAA
    Rev Recent Clin Trials; 2023; 18(3):181-205. PubMed ID: 37069722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple Sclerosis Disease-Modifying Therapy and the COVID-19 Pandemic: Implications on the Risk of Infection and Future Vaccination.
    Zheng C; Kar I; Chen CK; Sau C; Woodson S; Serra A; Abboud H
    CNS Drugs; 2020 Sep; 34(9):879-896. PubMed ID: 32780300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Highlight of Immune Pathogenic Response and Hematopathologic Effect in SARS-CoV, MERS-CoV, and SARS-Cov-2 Infection.
    Liang Y; Wang ML; Chien CS; Yarmishyn AA; Yang YP; Lai WY; Luo YH; Lin YT; Chen YJ; Chang PC; Chiou SH
    Front Immunol; 2020; 11():1022. PubMed ID: 32574260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current status in cellular-based therapies for prevention and treatment of COVID-19.
    Hattab D; Amer MFA; Mohd Gazzali A; Chuah LH; Bakhtiar A
    Crit Rev Clin Lab Sci; 2023 Aug; 60(5):321-345. PubMed ID: 36825325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.